GSK J1
Synonym(s):3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid; N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-Alanine;Histone Lysine Demethylase Inhibitor VII, GSK-J1 - CAS 1373422-53-7 - Calbiochem;JHDM Inhibitor II, 3-(6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoic acid
- CAS NO.:1373422-53-7
- Empirical Formula: C22H23N5O2
- Molecular Weight: 389.45
- MDL number: MFCD22683851
- EINECS: 200-258-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 15:53:33
What is GSK J1?
Description
GSK-J1 (1373422-53-7) is a potent and selective inhibitor of jumonji H3K27 histone demethylases JMJD3 and UTX (IC50 = 60 nM, human JMJD3). This is the first known inhibitor selective for the H3K27me3-specific JMJ subfamily which binds to the active catalytic site of the enzyme. The COOH group confers cell impermeability and as such GSK-J1 is useful as a standard in in vitro assays. A cell permeable ethyl ester analog is also available, see GSK-J4 (cat.# 10-1394).
The Uses of GSK J1
GSK J1 is a selective and potent inhibitor of JMJDE and UTX demethylases.
What are the applications of Application
GSK J1 is a selective and potent inhibitor of JMJDE and UTX demethylases
Definition
ChEBI: 3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid is an organonitrogen heterocyclic compound.
Biochem/physiol Actions
GSK-J1 is also termed as 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate. It may disturb the differentiation of specific neuronal subtypes in growing rat retina.
storage
room temperature (desiccate)
References
1) Kruidenier et al. (2012), A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response; Nature, 488 404
Properties of GSK J1
Boiling point: | 608.9±55.0 °C(Predicted) |
Density | 1.292±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: soluble15mg/mL, clear |
form | powder |
pka | 4.20±0.10(Predicted) |
color | white to beige |
Stability: | Stable for 2 years from date of purchase? as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
Safety information for GSK J1
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for GSK J1
InChIKey | AVZCPICCWKMZDT-UHFFFAOYSA-N |
New Products
Tert-butyl bis(2-chloroethyl)carbamate (S)-3-Aminobutanenitrile hydrochloride N-Boc-D-alaninol N-BOC-D/L-ALANINOL N-octanoyl benzotriazole 4-Hydrazinobenzoic acid 3,4-Dibenzyloxybenzaldehyde Electrolytic Iron Powder 1,1’-CARBONYLDIIMIDAZOLE R-2-BENZYLOXY PROPIONIC ACID 4-HYDROXY BENZYL ALCOHOL 1,1’-CARBONYLDI (1,2-4 TRIAZOLE) S-2-CHLORO PROPIONIC ACID (2-Hydroxyphenyl)acetonitrile 4-Bromopyrazole 5-BROMO-2CYANO PYRIDINE 5,6-Dimethoxyindanone 5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine 3-(2,4-Dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione 6-Bromo-3-iodo-1-methyl-1H-indazole 4-Ethylbenzylamine N-(5-Amino-2-methylphenyl)acetamide 2-(BOC-Amino)4-picoline 1-(4-Methylphenylsulfonyl)-1H-1,2,3-benzotriazoleRelated products of tetrahydrofuran
You may like
-
GSK-J1 >95% CAS 1373422-53-7View Details
1373422-53-7 -
GSK-J1 CAS 1373422-53-7View Details
1373422-53-7 -
100-71-0 99%View Details
100-71-0 -
Chloro Uracil 1820-81-1 99%View Details
1820-81-1 -
2-ethyl-6-methyl-3-hydroxypyridine succinate 127464-43-1 99%View Details
127464-43-1 -
13162-05-5 N-Vinylformamide 99%View Details
13162-05-5 -
1446013-08-6 98%View Details
1446013-08-6 -
Ste-Glu-AEEA-AEEA-OSUView Details
1169630-40-3